Financing will support lead program ALG-115 through IND-enabling studies toward clinical evaluation in lung transplantationRound was led by NBank ...

A first-of-its-kind drug for the sleep disorder offers a new treatment for people who live with the debilitating fog of ...

The 21st Annual Meeting of the International Conference on Genomics (ICG-21) was held at the BGI Center in Shenzhen from ...

Take a look at the Eli Lilly pipeline in 2026 as the incretin franchise grows and fuels the rest of the company's pipeline.

The last time Beecher High School’s original campus was open, life felt a bit different for seniors. The year was 2004. Kanye ...

Positive high-level results from a planned interim analysis of the DeLLphi-305 Phase III trial showed Imfinzi (durvalumab) plus Amgen's Imdelltra® ...

National Multiple Sclerosis Society, Lupus LA and over 60 organizations back ballot measure to stop debilitating ...

NanoViricides announces Phase II clinical trial registration for NV-387 oral gummies to treat Ebola in the Democratic Republic of Congo amid the largest outbreak.

More than 120 people packed the Fidalgo Bay RV Resort Event Center Saturday, Sept. 5, for the inaugural Bulletproof Brain ...

NanoViricides announces Phase II clinical trial for oral Ebola drug NV-387 registered in Pan African database, ready to treat patients amid growing DRC outbreak.

(NYSE American:NNVC) (the "Company"), a clinical stage leader developing antiviral drugs that viruses cannot escape, announces that its Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment ...

Your immune system's ability to move through those three phases efficiently is directly tied to what you eat, how you sleep, and how well you manage stress. All the things we talk about in this column ...